An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin
Authors:
- 15 February 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (2) , 215-219
Abstract
Five patients with B‐cell chronic lymphocytic leukemia (B‐CLL) were treated with 6 courses of the anti‐CD5 immunotoxin T101‐ricin A chain (T101‐RTA). Each course consisted of 8 bi‐weekly infusions of T101‐RTA (7 or 14 mg/m2). The immunotoxin was well tolerated in all cases with no major toxicities. Though saturation of circulating leukemic cell‐associated target antigen was demonstrated by FACS analysis in all patients, no intact immunotoxin was detected in bonemarrow or lymph‐node aspirates. Pharmacokinetic studies revealed rapid clearance of T101‐RTA, with a half‐life of 43 min. None of the patients developed detectable titers of antibody against either T101 murine antibody or ricin A chain. Clinical response was limited to a rapid and transient fall in WBC count lasting less than 24 hr, most likely secondary to the antibody portion of the conjugate. In vitro, fresh B‐CLL cells were resistant to T101‐RTA at concentrations up to 10−8M, while fresh malignant T‐cells with a 10‐fold increase in expression of CD5 antigen were sensitive. In the presence of the enhancing agent human serum albumin‐monensin, fresh B‐CLL cells were sensitive to T101‐RTA, with an ID50 more than 2 logs below the maximal concentration of immunotoxin achieved in vivo. We conclude that T101‐RTA is a potentially useful agent in the treatment of T‐cell leukemias. In the presence of HSA‐monensin, this spectrum of activity may be extended to B‐CLL.Keywords
This publication has 15 references indexed in Scilit:
- An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeysCancer Immunology, Immunotherapy, 1989
- Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxinJAMA, 1988
- Prevention of carbohydrate-mediated clearance of ricin-containing immunotoxins by the liver1988
- Immunotoxin enhancers1988
- Purification of immunotoxins containing ricin A-chain and abrin A-chain using Blue Sepharose CL-6BAnalytical Biochemistry, 1987
- Humoral Immune Response to a Ricin A Chain Immunotoxin in Patients with Metastatic MelanomaCancer Drug Delivery, 1987
- Prospects for Immunotoxin Therapy in CancerAnnual Review of Medicine, 1986
- Human immune response to multiple injections of murine monoclonal IgG.The Journal of Immunology, 1985
- Chronic Lymphocytic LeukemiaAnnals of Internal Medicine, 1985
- Single step separation of human T and B cells using AET treated SRBC rosettesJournal of Immunological Methods, 1976